Figure 3
From: Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment
Differentiation of pancreatic progenitor cells and formation of islet-like structures. (A) The endocrine cells differentiated from human fetal pancreatic progenitor cells, ×200. (B) Islet-like structure formed by the differentiated cells, ×100. (C) Native islet immunofluorescence stained for insulin (red) and glucagon (green), DAPI used for nuclei staining (blue), ×400. (D) Progenitor cell-derived islet immunofluorescence stained for insulin (red) and glucagon (green), DAPI used for nuclei staining (blue), ×400. DAPI, 4',6-diamidino-2-phenylindole.